ATRIP and breast cancer: We detected ATRIP c.1152_1155del (p.Gly385Ter) founder mutation in 42 of 16,085 unselected Polish breast cancer patients and in 11 of 9285 cancer-free women (OR = 2.14, 95% CI 1.13–4.28, p = 0.02).